ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 853–864 of 2020 project topics
Fusion Gene Detection in Cancer by RNA Sequencing
Developing RNA sequencing-based fusion gene detection pipelines for identifying targetable driver fusions in lung, sarcoma, and hematological cancers.
Precision Oncology Genetics Click to view more details →
ctDNA Monitoring for Treatment Response Assessment
Implementing circulating tumor DNA assays for monitoring treatment response and early resistance detection in targeted cancer therapy clinical applications.
Precision Oncology Genetics Click to view more details →
Microsatellite Instability Classification SaaS Platform
A cloud-based diagnostic platform that automatically detects and classifies microsatellite instability (MSI) status from tumor sequencing data to predict immunotherapy response. This enables oncology labs to offer MSI-based patient stratification services, commanding premium pricing for precision treatment recommendations.
Precision Oncology Genetics Click to view more details →
Germline Cancer Predisposition Gene Risk Scoring Tool
An AI-powered software tool that analyzes germline mutations in BRCA1/2, Lynch syndrome, and other hereditary cancer genes to generate quantified lifetime risk assessments for patients. This creates recurring revenue through clinical laboratory licensing and direct-to-consumer genomic risk reporting services.
Precision Oncology Genetics Click to view more details →
Pharmacogenomic Oncology Drug Metabolism Prediction Engine
A precision medicine platform that predicts patient-specific chemotherapy metabolism and toxicity risk based on pharmacogenomic variants to optimize dosing regimens. This generates value through partnerships with pharmaceutical companies, hospital systems, and personalized medicine clinics seeking to reduce adverse events and improve treatment outcomes.
Precision Oncology Genetics Click to view more details →
Clonal Evolution Tracking Dashboard for Liquid Biopsies
An integrated analytics dashboard that monitors sub-clonal populations and mutation evolution in blood-based cancer biopsies to detect treatment resistance before clinical progression. This unlocks subscription revenue from oncology centers requiring real-time patient monitoring and proactive therapeutic intervention guidance.
Precision Oncology Genetics Click to view more details →
Immunogenicity Prediction Platform for Neoantigen Vaccines
A machine learning platform that predicts which patient-specific cancer neoantigens will generate robust immune responses to optimize personalized vaccine design and patient selection. This creates B2B partnerships with immunotherapy companies and generates licensing fees for clinical implementation in precision oncology centers.
Precision Oncology Genetics Click to view more details →
Somatic Copy Number Alteration Segmentation and Risk Assessment
A commercial bioinformatics tool that segments and classifies copy number alterations to identify prognostic signatures and predict chemotherapy sensitivity across tumor types. This generates revenue through white-label laboratory services, enterprise licensing to healthcare systems, and integration into clinical decision support workflows.
Precision Oncology Genetics Click to view more details →
Hereditary Pancreatitis Gene Mutation Analysis
Characterizing PRSS1, SPINK1, and CFTR variants causing hereditary pancreatitis for molecular diagnosis and pancreatic cancer risk counseling.
Genetic Basis of Pancreatic Disorders Click to view more details →
MODY Genetic Classification and Testing
Developing testing algorithms for distinguishing MODY from T1D and T2D and genotyping GCK, HNF1A, HNF4A, and other MODY genes.
Genetic Basis of Pancreatic Disorders Click to view more details →
Neonatal Diabetes Molecular Diagnosis
Applying gene panels for KCNJ11, ABCC8, and INS mutations causing neonatal diabetes for identifying patients eligible for sulfonylurea therapy switch.
Genetic Basis of Pancreatic Disorders Click to view more details →
Pancreatic Cancer Genetic Risk Assessment
Evaluating BRCA2, PALB2, ATM, and other genes for pancreatic cancer risk and developing surveillance recommendations for high-risk individuals.
Genetic Basis of Pancreatic Disorders Click to view more details →